Minimal relapse risk and early normalization of survival for patients with Burkitt lymphoma treated with intensive immunochemotherapy: an international study of 264 real-world patients.
Br J Haematol
; 189(4): 661-671, 2020 05.
Article
in En
| MEDLINE
| ID: mdl-32017050
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Burkitt Lymphoma
Type of study:
Etiology_studies
/
Guideline
/
Observational_studies
/
Risk_factors_studies
Limits:
Adolescent
/
Adult
/
Aged
/
Aged80
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Br J Haematol
Year:
2020
Document type:
Article
Affiliation country: